Key Events This Week
Jan 27: Stock surges 4.70% on strong volume
Jan 28: Intraday high of Rs.1,868 with 7.84% gain; stellar Q3 FY26 results announced
Jan 29: New 52-week and all-time high at Rs.1,947.55; financial trend upgraded
Jan 30: Minor correction of -1.35% closes the week at Rs.1,909.80
Monday, 27 January 2026: Strong Start with 4.70% Gain
Acutaas Chemicals Ltd began the week on a positive note, closing at Rs.1,728.95, up Rs.77.55 or 4.70% on volume of 16,350 shares. This gain outpaced the Sensex’s 0.50% rise to 35,786.84, signalling early buying interest. The stock’s strong performance was supported by positive sentiment in the Pharmaceuticals & Biotechnology sector and anticipation of upcoming quarterly results.
Tuesday, 28 January 2026: Intraday High and Stellar Quarterly Results
The stock surged further on 28 January, closing at Rs.1,864.45, a gain of Rs.135.50 or 7.84%, on heavy volume of 72,305 shares. It reached an intraday high of Rs.1,868, marking a 7.77% intraday surge and nearing its 52-week high of Rs.1,901.35. This rally was driven by the announcement of an outstanding Q3 FY26 performance, with net sales hitting ₹393.18 crores—the highest quarterly revenue in company history—and operating profit margin expanding to 38.32%. Profit after tax rose to ₹107.96 crores, with EPS at ₹13.19, reflecting strong bottom-line growth.
On the same day, the Sensex gained 1.12% to close at 36,188.16, but Acutaas Chemicals outperformed both the benchmark and its sector peers, which advanced 5.06%. The stock’s technical indicators remained bullish, trading above all key moving averages, signalling sustained momentum.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Wednesday, 29 January 2026: New 52-Week and All-Time Highs Amid Financial Trend Upgrade
Acutaas Chemicals Ltd reached a new 52-week and all-time high of Rs.1,947.55 on 29 January, closing at Rs.1,936.00, up Rs.71.55 or 3.84%. This marked the fifth consecutive day of gains, delivering a cumulative return of 18.58% over this period. The stock outperformed the Sensex, which declined 0.22% to 36,266.59, and its Pharmaceuticals & Biotechnology sector peers by 4.79% on the day.
The company’s financial trend was upgraded from very positive to outstanding, reflecting record quarterly revenue, profit, and operational efficiency. Key metrics included a return on capital employed (ROCE) of 21.30%, inventory turnover ratio of 5.74 times, and debtor turnover ratio of 3.76 times. Institutional investors hold a significant 38.38% stake, underscoring confidence in the company’s fundamentals.
Technical momentum also shifted strongly, with the Mojo Score rising to 82.0 and the Mojo Grade upgraded to Strong Buy. The stock traded above all major moving averages, supported by bullish MACD and Bollinger Bands signals on monthly charts, despite some short-term caution indicated by weekly momentum indicators.
Thursday, 30 January 2026: Minor Correction Closes the Week
The stock experienced a slight pullback on the final trading day, closing at Rs.1,909.80, down Rs.26.20 or 1.35%, on volume of 28,114 shares. This minor correction followed a strong rally and coincided with a 0.22% decline in the Sensex to 36,185.03. Despite the dip, the stock maintained a substantial weekly gain of 15.65%, reflecting sustained investor interest and strong underlying fundamentals.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-01-27 | Rs.1,728.95 | +4.70% | 35,786.84 | +0.50% |
| 2026-01-28 | Rs.1,864.45 | +7.84% | 36,188.16 | +1.12% |
| 2026-01-29 | Rs.1,936.00 | +3.84% | 36,266.59 | +0.22% |
| 2026-01-30 | Rs.1,909.80 | -1.35% | 36,185.03 | -0.22% |
Key Takeaways from the Week
Robust Price Performance: Acutaas Chemicals Ltd outperformed the Sensex by a wide margin, gaining 15.65% versus the benchmark’s 1.62%, driven by strong earnings and technical momentum.
Record Quarterly Results: The company reported its highest-ever quarterly revenue and profit, with net sales of ₹393.18 crores and profit after tax of ₹107.96 crores, underpinning the stock’s rally.
Technical Strength: Trading above all key moving averages and supported by bullish momentum indicators, the stock’s technical profile improved significantly, culminating in a Mojo Grade upgrade to Strong Buy.
Valuation and Institutional Confidence: Despite a premium price-to-book ratio of 10.8, institutional holdings of 38.38% and strong operational metrics such as ROCE of 21.30% reflect solid fundamentals and market trust.
Short-Term Volatility: The minor correction on 30 January suggests some profit-taking, but neutral RSI readings and strong monthly momentum indicators imply potential for further gains.
Curious about Acutaas Chemicals Ltd from ? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Conclusion
Acutaas Chemicals Ltd’s performance in the week ending 30 January 2026 highlights a compelling combination of strong financial results, technical momentum, and market recognition. The stock’s 15.65% weekly gain, driven by record quarterly earnings and a new all-time high, significantly outpaced the Sensex’s modest 1.62% rise. The upgrade to a Strong Buy Mojo Grade and robust operational metrics such as a 21.30% ROCE and high turnover ratios underscore the company’s quality and growth potential within the Pharmaceuticals & Biotechnology sector.
While the slight correction on the final trading day indicates some short-term profit-taking, the overall trend remains bullish with solid institutional backing and favourable technical indicators. Investors monitoring Acutaas Chemicals should consider its premium valuation in the context of sustained earnings growth and sector leadership. The company’s ability to maintain operational excellence and capitalise on market opportunities will be key to sustaining this upward trajectory in the coming months.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
